Dhillon Punit

Chief Executive Officer, DirectorSkye Bioscience, Inc. (SKYE) · full profile →Form 4/A · filed Aug 31, 2023
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2023Buy(P)881K$0.02$18K25.7M
Aug 28, 2023Small acquisition(L)110K$0.02$2K24.8M
Aug 25, 2023Grant(A)20.3M24.7M
Aug 23, 2023Small acquisition(L)9K$0.01$9024.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2023Grant(A)2.3M$02.3M

Transaction Codes

P
Open-market purchase
L
See SEC Form 4 code table
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001516551-23-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly: